Showing results (641-650 of 3,635) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|November 12, 2013
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapyValentina Rossi, Franco Nolè, Stefania Redana, et al.Breast (Edinburgh, Scotland)|November 12, 2013
Risk reducing mastectomy, breast reconstruction and patient satisfaction in Norwegian BRCA1/2 mutation carriersAnne Irene Hagen, Lovise Mæhle, Nina Vedå, et al.Breast (Edinburgh, Scotland)|November 13, 2013
Primary and secondary distant metastatic breast cancer: two sides of the same coinUwe Güth, Isotta Magaton, Dorothy Jane Huang, et al.Breast (Edinburgh, Scotland)|November 27, 2013
Contralateral prophylactic mastectomy in an Asian population: a single institution reviewYirong Sim, Veronique Kiak Mien Tan, Gay Hui Ho, et al.Breast (Edinburgh, Scotland)|August 26, 2014
Smartphone breast applications - what's the evidence?Mohammad H Mobasheri, Maximilian Johnston, Dominic King, et al.Breast (Edinburgh, Scotland)|October 14, 2014
Impact of breast cancer treatments on sleep disturbances - A systematic reviewAna Rute Costa, Filipa Fontes, Susana Pereira, et al.Breast (Edinburgh, Scotland)|April 2, 2026
Improving CTVboost delineation after preoperative systemic therapy in breast cancer using deformable PET/CT registrationJordy Kemmeugne, Lyse Gallay, David Morland, et al.Breast (Edinburgh, Scotland)|March 26, 2026
Clinical effect of bisphosphonate in patients with hormone receptor-positive early breast cancer: A nationwide real-world data analysisWonseok Choi, Minwoong Kang, Kyoungmin Lee, et al.Breast (Edinburgh, Scotland)|March 18, 2026
Modification of RECIST 1.1 criteria for assessing response in breast tumours treated with radiation therapy using multiparametric breast MRI: Radiology and oncology perspectiveE Durie, M Morris, N A Healy, et al.Breast (Edinburgh, Scotland)|March 21, 2026
Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)Mark Opdam, Nigel Ultee, Jill J J Geenen, et al.Pageof 364